<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK43797" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK43797/" /><meta name="ncbi_pagename" content="TP63-Related Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>TP63-Related Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="TP63-Related Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/12/05" /><meta name="citation_author" content="V Reid Sutton" /><meta name="citation_author" content="Hans van Bokhoven" /><meta name="citation_pmid" content="20556892" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK43797/" /><meta name="citation_keywords" content="Ectrodactyly, Ectodermal Dysplasia, Cleft Lip/Palate Syndrome 3 (EEC3)" /><meta name="citation_keywords" content="Split-Hand/Foot Malformation Type 4 (SHFM4)" /><meta name="citation_keywords" content="Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate Syndrome (AEC Syndrome)" /><meta name="citation_keywords" content="Limb-Mammary Syndrome" /><meta name="citation_keywords" content="Acro-Dermo-Ungual-Lacrimal-Tooth Syndrome (ADULT Syndrome)" /><meta name="citation_keywords" content="Isolated Cleft Lip/Cleft Palate (Orofacial Cleft 8)" /><meta name="citation_keywords" content="Tumor protein 63" /><meta name="citation_keywords" content="TP63" /><meta name="citation_keywords" content="TP63-Related Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="TP63-Related Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="V Reid Sutton" /><meta name="DC.Contributor" content="Hans van Bokhoven" /><meta name="DC.Date" content="2019/12/05" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK43797/" /><meta name="description" content="The TP63-related disorders comprise six overlapping phenotypes:" /><meta name="og:title" content="TP63-Related Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="The TP63-related disorders comprise six overlapping phenotypes:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK43797/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/aec/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK43797/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8AEEDBE040FA5100000000021F00BF.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK43797_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK43797_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/tk2-mtddepl/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/trio-id/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK43797_"><span class="title" itemprop="name"><i>TP63</i>-Related Disorders</span></h1><p class="contrib-group"><span itemprop="author">V Reid Sutton</span>, MD and <span itemprop="author">Hans van Bokhoven</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK43797_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK43797_ai__"><div class="contrib half_rhythm"><span itemprop="author">V Reid Sutton</span>, MD<div class="affiliation small">Professor, Department of Molecular and Human Genetics<br />Baylor College of Medicine &#x00026; Texas Children&#x02019;s Hospital<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.snerdlihcsaxet@nottusrv" class="oemail">gro.snerdlihcsaxet@nottusrv</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Hans van Bokhoven</span>, PhD<div class="affiliation small">Professor, Molecular Neurogenetics<br />Department of Human Genetics<br />Radboud University Medical Center<br />Nijmegen, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuduobdar@nevohkobnav.snah" class="oemail">ln.cmuduobdar@nevohkobnav.snah</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 8, 2010</span>; Last Revision: <span itemprop="dateModified">December 5, 2019</span>.</p><p><em>Estimated reading time: 27 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="aec.Summary" itemprop="description"><h2 id="_aec_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The <i>TP63</i>-related disorders comprise six overlapping phenotypes:</p><ul><li class="half_rhythm"><div>Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome (which includes Rapp-Hodgkin syndrome)</div></li><li class="half_rhythm"><div>Acro-dermo-ungual-lacrimal-tooth (ADULT) syndrome</div></li><li class="half_rhythm"><div>Ectrodactyly, ectodermal dysplasia, cleft lip/palate syndrome 3 (EEC3)</div></li><li class="half_rhythm"><div>Limb-mammary syndrome</div></li><li class="half_rhythm"><div>Split-hand/foot malformation type 4 (SHFM4)</div></li><li class="half_rhythm"><div>Isolated cleft lip/cleft palate (orofacial cleft 8)</div></li></ul><p>Individuals typically have varying combinations of ectodermal dysplasia (subjective hypohidrosis, nail dysplasia, sparse hair, tooth abnormalities), cleft lip/palate, split-hand/foot malformation/syndactyly, lacrimal duct obstruction, hypopigmentation, and hypoplastic breasts and/or nipples. Findings associated with a single <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> include ankyloblepharon filiforme adnatum (tissue strands that completely or partially fuse the upper and lower eyelids), skin erosions especially on the scalp associated with areas of scarring and alopecia, hypospadias, trismus, and excessive freckling.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis is based on clinical findings and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>TP63</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> A multidisciplinary team of specialists in clinical genetics, dermatology, ophthalmology, otolaryngology, audiology, dentistry and prosthodontics, plastic surgery, gastroenterology, and psychiatry is recommended. Wigs can be used for sparse hair and alopecia; dentures may be considered in early childhood and dental implants in the teens or early adulthood. Skin erosions are treated with gentle wound care and periodic, dilute bleach soaks to prevent secondary infection. Cleft lip/palate is managed as per routine protocols with attention to feeding in infancy, recurrent otitis media, and speech therapy.</p><p><i>Prevention of secondary complications:</i> Infants with severe skin erosions need aggressive monitoring/treatment of dehydration, electrolyte imbalances, malnutrition, and secondary infection and sepsis.</p><p><i>Surveillance:</i> Regular evaluation with a multidisciplinary team with attention to dental needs and possible hearing loss.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>The <i>TP63</i>-related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Approximately 30% of individuals have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent and approximately 70% have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Each child of an individual with a <i>TP63</i>-related disorder has a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis for pregnancies at increased risk is possible if the <i>TP63</i> pathogenic variant in the family is known.</p></div></div><div id="aec.GeneReview_Scope"><h2 id="_aec_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="aec.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK43797/table/aec.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__aec.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_aec.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>TP63</i>-Related Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_aec.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome (AEC syndrome)</div><ul><li class="half_rhythm"><div>Rapp-Hodgkin syndrome</div></li></ul></li><li class="half_rhythm"><div>Acro-dermo-ungual-lacrimal-tooth syndrome (ADULT syndrome)</div></li><li class="half_rhythm"><div>Ectrodactyly, ectodermal dysplasia, cleft lip/palate syndrome 3 (EEC3)</div></li><li class="half_rhythm"><div>Limb-mammary syndrome</div></li><li class="half_rhythm"><div>Split-hand/foot malformation type 4 (SHFM4)</div></li><li class="half_rhythm"><div>Isolated cleft lip/cleft palate (orofacial cleft 8)</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#aec.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="aec.TF.c.1"><p class="no_margin">For other genetic causes of these phenotypes, see <a href="#aec.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="aec.Diagnosis"><h2 id="_aec_Diagnosis_">Diagnosis</h2><div id="aec.Suggestive_Findings"><h3>Suggestive Findings</h3><p><b>The <i>TP63</i>-related disorders</b> include the following overlapping phenotypes (summarized in <a class="figpopup" href="/books/NBK43797/table/aec.T.clinical_features_of_tp63related_d/?report=objectonly" target="object" rid-figpopup="figaecTclinicalfeaturesoftp63relatedd" rid-ob="figobaecTclinicalfeaturesoftp63relatedd">Table 1</a>).</p><p><b>Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome</b></p><ul><li class="half_rhythm"><div class="half_rhythm">Ankyloblepharon filiforme adnatum typically manifest as strands of tissue that completely or partially fuse the upper and lower eyelids. In the latter instance, they may be barely perceptible and lyse spontaneously. Although a definitive part of the syndrome, ankyloblepharon may not be present or detected in up to 50% of cases.</div></li><li class="half_rhythm"><div class="half_rhythm">Ectodermal defects typically manifest as sparse wiry hair, skin erosions and unique pigmentary skin changes, nail changes, dental changes, and subjective decrease in sweating capacity.</div><div class="half_rhythm">Note: (1) Starch iodide sweat testing of the palms is rarely helpful in documenting sweating ability. (2) Scalp erosions are characteristic of AEC syndrome and are NOT seen in other <i>TP63-</i>related disorders.</div></li><li class="half_rhythm"><div class="half_rhythm">Cleft lip/palate presents in nearly 100%; the spectrum includes submucous cleft palate only, cleft of the soft and/or the hard palate only, cleft lip only, and the combination of cleft lip and cleft palate. In a series of 18 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals: 44% had cleft lip (~1/3 bilateral); 100% had some form of palatal cleft (cleft hard palate: 56%; cleft soft palate: 89%; submucous cleft palate: 17%).</div></li><li class="half_rhythm"><div class="half_rhythm">Craniofacial findings include the following:</div><ul><li class="half_rhythm"><div>Maxillary hypoplasia (reported in 94%)</div></li><li class="half_rhythm"><div>Small mandible (reported in 65%)</div></li><li class="half_rhythm"><div>Broad nasal bridge (76%)</div></li><li class="half_rhythm"><div>Hypoplastic alae nasi (94%)</div></li><li class="half_rhythm"><div>Thin vermilion border of the upper lip (82%)</div></li><li class="half_rhythm"><div>Microstomia (94%)</div></li><li class="half_rhythm"><div>Trismus (44%)</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm">Hypospadias has been reported in 80% of males.</div></li></ul><p>Note: Rapp-Hodgkin syndrome (RHS), once thought to be a separate entity, is now considered to be part of the spectrum of the AEC syndrome because of the overlap of clinical manifestations and <i>TP63</i> pathogenic variants observed in the two conditions [<a class="bk_pop" href="#aec.REF.cambiaghi.1994.97">Cambiaghi et al 1994</a>, <a class="bk_pop" href="#aec.REF.bertola.2004.79">Bertola et al 2004</a>].</p><p><b>Acro-dermo-ungual-lacrimal-tooth (ADULT) syndrome</b></p><ul><li class="half_rhythm"><div>Acromelic malformation is present in the form of split hand and/or split foot with or without syndactyly.</div></li><li class="half_rhythm"><div>Dermatologic abnormalities include sparse fine hair; dry skin, and unique pigmentary skin changes.</div><ul><li class="half_rhythm"><div>Excessive freckling in sun-exposed areas is common and progresses with age and sun exposure. It is unique to ADULT syndrome and not characteristic of other <i>TP63&#x02013;</i>related disorders.</div></li><li class="half_rhythm"><div>There may be subjective decrease in sweating capacity. Note: Starch iodide sweat testing of the palms is rarely helpful in documenting sweating ability.</div></li></ul></li><li class="half_rhythm"><div>Ungual defects manifest as hypoplastic, dysplastic, absent, and/or ridged nails.</div></li><li class="half_rhythm"><div>Lacrimal puncta absence is seen in many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li><li class="half_rhythm"><div>Tooth abnormalities include hypodontia or oligodontia.</div></li><li class="half_rhythm"><div>Breast and/or nipple hypoplasia that may be symmetric or asymmetric is typically seen in ADULT syndrome and limb-mammary syndrome and not in other <i>TP63-</i>related disorders.</div></li></ul><p><b>Ectrodactyly, ectodermal dysplasia, cleft lip/palate syndrome 3 (EEC3)</b></p><ul><li class="half_rhythm"><div class="half_rhythm">Ectrodactyly (now referred to as split-hand/foot malformation) with or without syndactyly is present in approximately 70% of all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and ranges widely in severity and location of the digital abnormalities [<a class="bk_pop" href="#aec.REF.rinne.2006.1396">Rinne et al 2006a</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Ectodermal defects typically manifest as silvery-blond, sparse fine hair; dry skin and unique pigmentary skin changes; nail changes; dental changes including oligodontia and enamel defects; and xerostomia and subjective decrease in sweating capacity.</div><div class="half_rhythm">Note: Starch iodide sweat testing of the palms is rarely helpful in documenting sweating ability.</div></li><li class="half_rhythm"><div class="half_rhythm">Cleft lip/palate is present in approximately 40% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#aec.REF.rinne.2006.1396">Rinne et al 2006a</a>]; the spectrum includes submucous cleft palate only, cleft of the soft and/or the hard palate only, cleft lip only, and the combination of cleft lip and cleft palate.</div></li><li class="half_rhythm"><div class="half_rhythm">Other</div><ul><li class="half_rhythm"><div>Absent lacrimal puncta is seen in almost all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li><li class="half_rhythm"><div>Blepharophimosis is seen occasionally.</div></li><li class="half_rhythm"><div>Hypospadias has been reported often in males.</div></li></ul></li></ul><p><b>Limb-mammary syndrome</b></p><ul><li class="half_rhythm"><div>Limb abnormalities can include split-hand/foot malformation, oligodactyly, and syndactyly.</div></li><li class="half_rhythm"><div>Breast and/or nipple hypoplasia has been reported in 90% of individuals with limb-mammary syndrome [<a class="bk_pop" href="#aec.REF.van_bokhoven.1999.538">van Bokhoven et al 1999</a>]. It may be symmetric or asymmetric, and is typical for ADULT syndrome and limb-mammary syndrome and rarely seen in other <i>TP63-</i>related disorders.</div></li><li class="half_rhythm"><div>Less common findings</div><ul><li class="half_rhythm"><div>Absent lacrimal puncta and lacrimal duct atresia is seen in half of all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li><li class="half_rhythm"><div>Cleft lip/palate is present in one quarter to one third of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals; the spectrum includes submucous cleft palate only, cleft of the soft and/or the hard palate only, cleft lip only, and the combination of cleft lip and cleft palate.</div></li><li class="half_rhythm"><div>Hypodontia and nail dysplasia is found in a small percentage of individuals; skin and hair abnormalities are NOT seen.</div></li></ul></li></ul><p><b>Split-hand/foot malformation type 4 (SHFM4)</b></p><ul><li class="half_rhythm"><div>Split hand/foot with or without syndactyly is present in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and ranges widely in severity and location. Aplasia or hypoplasia of phalanges and metacarpals is seen.</div></li><li class="half_rhythm"><div>Ectodermal abnormalities and cleft lip/palate are very rarely seen.</div></li></ul><p><b>Isolated cleft lip/cleft palate (orofacial cleft 8).</b> Cleft lip/palate includes a wide spectrum ranging from submucous cleft palate only to cleft of the soft and/or the hard palate only, cleft lip only, and the combination of cleft lip and cleft palate.</p><div id="aec.T.clinical_features_of_tp63related_d" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Clinical Features of <i>TP63</i>-Related Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK43797/table/aec.T.clinical_features_of_tp63related_d/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__aec.T.clinical_features_of_tp63related_d_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" style="text-align:left;vertical-align:middle;">Feature</th><th id="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2" colspan="6" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;"><i>TP63</i>-Related Disorder</th></tr><tr><th headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2" id="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">AEC</th><th headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2" id="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ADULT</th><th headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2" id="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EEC3</th><th headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2" id="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Limb-<br />Mammary</th><th headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2" id="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SHFM4</th><th headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2" id="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Isolated<br />CL/P</th></tr></thead><tbody><tr><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ankyloblepharon filiforme adnatum</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ectodermal dysplasia:</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypohidrosis (mostly subjective)</div></li></ul>
</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Nail dysplasia</div></li></ul>
</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Sparse hair</div></li></ul>
</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Tooth abnormalities</div></li></ul>
</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cleft lip/palate</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Split-hand/foot malformation/syndactyly</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lacrimal duct obstruction</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dermal erosions</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypopigmentation</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypospadias</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Trismus</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Excessive freckling</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypoplastic breasts</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypoplastic nipples</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ADULT = acro-dermato-ungual-lacrimal-tooth; CL/P = cleft lip/cleft palate; EEC = ectrodactyly (split-hand/foot malformation), ectodermal dysplasia, clefting; SHFM4 = split-hand/foot malformation type 4</p></div></dd></dl></div></div></div></div><div id="aec.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of a <i>TP63</i>-related disorder is established by identification of a <i>TP63</i> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK43797/table/aec.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figaecTmoleculargenetictestingusedin" rid-ob="figobaecTmoleculargenetictestingusedin">Table 2</a>).</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>TP63</i> is performed first followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>TP63</i> and other genes of interest (see <a href="#aec.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="aec.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>TP63</i> Related Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK43797/table/aec.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__aec.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_aec.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_aec.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_aec.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_aec.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>TP63</i></td><td headers="hd_h_aec.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_aec.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">75%-100%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_aec.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_aec.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="aec.TF.2.1"><p class="no_margin">See <a href="/books/NBK43797/#aec.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="aec.TF.2.2"><p class="no_margin">See <a href="#aec.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="aec.TF.2.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="aec.TF.2.4"><p class="no_margin"><a class="bk_pop" href="#aec.REF.van_bokhoven.2001.481">van Bokhoven et al [2001]</a>, <a class="bk_pop" href="#aec.REF.rinne.2009.1948">Rinne et al [2009]</a></p></div></dd><dt>5. </dt><dd><div id="aec.TF.2.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="aec.TF.2.6"><p class="no_margin">A single case report of a four-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>TP63</i> has been reported in an individual with EEC [<a class="bk_pop" href="#aec.REF.aradhya.2012.594">Aradhya et al 2012</a>].</p></div></dd></dl></div></div></div></div></div><div id="aec.Clinical_Characteristics"><h2 id="_aec_Clinical_Characteristics_">Clinical Characteristics</h2><div id="aec.Clinical_Description"><h3>Clinical Description</h3><div id="aec.AEC_Syndrome"><h4>AEC Syndrome</h4><p>The manifestations of ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome are typically present at birth.</p><p><b>Ankyloblepharon</b> is present in 70% of neonates. While the upper- and lower-eyelid adhesions can be obvious, partial adhesion of the upper and lower eyelids can be subtle and these filiforme adhesions can spontaneously lyse before they are recognized as such.</p><p>Lacrimal puncta are frequently absent, often leading to chronic conjunctivitis and blepharitis which is often not recognized in infancy but rather seen in early childhood [<a class="bk_pop" href="#aec.REF.sutton.2009.1916">Sutton et al 2009</a>].</p><p><b>Ectodermal defects</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Skin.</b> Nearly 100% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> neonates have superficial skin erosions that vary from very limited to severe, life-threatening full-body involvement. The erosions most typically affect the scalp at birth and during infancy. Severe scalp erosions often lead to scarring alopecia and hypotrichosis. This is NOT seen in other <i>TP63-</i>related disorders.</div><div class="half_rhythm">The skin erosions tend to be recurrent and intermittent throughout childhood and into adulthood with frequent involvement of the head and neck, palms, soles, and skin folds.</div><div class="half_rhythm">Congenital erythroderma (i.e. diffuse erythema with associated erosions) is observed in 70%-90% of infants. The skin can also appear shiny with a collodion membrane (red, shiny, membranous skin changes) [<a class="bk_pop" href="#aec.REF.siegfried.2005.1591">Siegfried et al 2005</a>].</div><div class="half_rhythm">Children typically manifest cutaneous depigmentation and scarring, most likely due to postinflammatory pigmentary changes related to previous erythroderma and associated underlying erosions which may or may not be appreciated clinically. African American infants can have facial hypopigmentation in a mask pattern that improves with age. Affected individuals with fair skin typically have a reticulated hyperpigmentation on the neck and intertriginous areas that progresses with age to cribiform, reticulate, stellate, or punctate scarring most commonly on the shoulders, upper back, and chest.</div><div class="half_rhythm">Histopathologic features of skin biopsies may reveal epidermal atrophy, pigment incontinence, and a prominent superficial perivascular plexus with limited lymphocytic infiltrate [<a class="bk_pop" href="#aec.REF.dishop.2009.1935">Dishop et al 2009</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Hair changes</b> become more obvious with age. Hair is typically light-colored and coarse, wiry, and brittle with a spun glass/gold or &#x0201c;uncombable&#x0201d; appearance. Eyebrows and eyelashes are sparse. Light and scanning microscopy may reveal structural and pigmentary alterations of the hair including kinking, grooves, and discontinuous pigmentation.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Nail</b>
<b>changes,</b> present in all and more obvious with age, vary among individuals. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have nail dystrophy (abnormal nail plate texture) and hyperconvex nail plates. Micronychia (abnormally small nail plates), distal frayed edges with nail plate resorption, and absent nails are also frequent [<a class="bk_pop" href="#aec.REF.julapalli.2009.1900">Julapalli et al 2009</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Dental anomalies.</b> Malformed teeth (conical shape with small occlusal tables) and hypodontia (reduced number of teeth) also become evident during childhood and adolescence. Affected adults have an average of 4.75 secondary teeth [<a class="bk_pop" href="#aec.REF.farrington.2009.1907">Farrington &#x00026; Lausten 2009</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Sweating.</b> Subjective decreased sweat production is universal and is reported as heat intolerance; however, this does <b>not</b> lead to hyperthermia or fevers as seen in <a href="/books/n/gene/x-hed/">hypohidrotic ectodermal dysplasia</a>.</div></li></ul><p><b>Clefting</b> is present in all. Clefting can include submucous cleft palate only, cleft of the soft and/or the hard palate only, cleft lip only, or the combination of cleft lip and cleft palate [<a class="bk_pop" href="#aec.REF.cole.2009.1910">Cole et al 2009</a>].</p><p><b>Other</b> findings include the following:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Limb anomalies</b> were initially not considered to be part of the syndrome, but syndactyly of fingers and toes and/or camptodactyly (permanent and irreducible flexion of the fingers) of hands have been seen. Split-hand/foot malformation was observed in 2/17 individuals (12%) with AEC syndrome [<a class="bk_pop" href="#aec.REF.sutton.2009.1916">Sutton et al 2009</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Hypospadias</b> has been reported in 78% of males with AEC syndrome [<a class="bk_pop" href="#aec.REF.sutton.2009.1916">Sutton et al 2009</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Facial features</b> become more distinctive with age. Findings commonly include maxillary hypoplasia, micrognathia, broad nasal root, underdeveloped alae nasi, thin vermilion of the upper lip, and short philtrum.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Trismus</b> has been reported in 35% of individuals with AEC syndrome [<a class="bk_pop" href="#aec.REF.sutton.2009.1916">Sutton et al 2009</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Hearing loss.</b> More than 90% of children have conductive hearing loss, often with secondary speech delay [<a class="bk_pop" href="#aec.REF.cole.2009.1910">Cole et al 2009</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Growth.</b> Poor weight gain and failure to thrive should be anticipated. When treated appropriately with nutritional supplementation poor weight gain improves with age.</div><div class="half_rhythm">Linear growth abnormalities are observed in early childhood with a significantly lower height for age compared to the reference population. The growth pattern in AEC is similar to that reported for hypohidrotic ectodermal dysplasia [<a class="bk_pop" href="#aec.REF.motil.2009.1922">Motil &#x00026; Fete 2009</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Psychological impact</b> related to the phenotypic features of the disease can include a reduced quality of life with negative impact on both child and family. In one study, a variable degree of psychological functioning was noted with some families reporting few ill effects from the disease while others reported significant impact [<a class="bk_pop" href="#aec.REF.lane.2009.1926">Lane et al 2009</a>].</div></li></ul></div><div id="aec.ADULT_Syndrome"><h4>ADULT Syndrome</h4><p>The manifestations of acro-dermato-ungual-lacrimal-tooth (ADULT) syndrome are typically present at birth (although they may become more prominent with age), with the exception of skin freckling.</p><p><b>Limb anomalies.</b> Most commonly seen is syndactyly of fingers and toes.</p><p><b>Ectodermal defects</b></p><ul><li class="half_rhythm"><div><b>Skin</b> tends to be dry but erosions are not present.</div></li><li class="half_rhythm"><div><b>Hair changes</b> are more obvious with age. Hair is typically light-colored and fine. Eyebrows and eyelashes are sparse.</div></li><li class="half_rhythm"><div><b>Nail dysplasia</b> is commonly reported.</div></li><li class="half_rhythm"><div><b>Dental anomalies.</b> Malformed teeth (conical shape with small occlusal tables) and hypodontia (reduced number of teeth) also become evident during childhood and adolescence.</div></li><li class="half_rhythm"><div><b>Sweating.</b> Subjective decreased sweat production is universal and is reported as heat intolerance; however, this does <b>not</b> lead to hyperthermia or fevers as seen in <a href="/books/n/gene/x-hed/">hypohidrotic ectodermal dysplasia</a>.</div></li></ul><p><b>Lacrimal duct atresia</b> is frequent and often leads to chronic conjunctivitis and blepharitis, which are often not recognized until early childhood [<a class="bk_pop" href="#aec.REF.sutton.2009.1916">Sutton et al 2009</a>].</p><p><b>Breast and/or nipple hypoplasia</b> is seen commonly and most notably in females. This feature is characteristic of ADULT and limb-mammary syndrome and NOT typically seen in other <i>TP63-</i>related disorders.</p><p><b>Excessive freckling</b> in sun exposed areas is seen in a subset of patients and progresses with age and sun exposure. This feature is NOT seen in other <i>TP63-</i>related disorders.</p></div><div id="aec.EEC3_Syndrome"><h4>EEC3 Syndrome</h4><p>The manifestations of ectrodactyly, ectodermal dysplasia, cleft lip/palate syndrome 3 (EEC3) are typically present at birth.</p><p><b>Limb anomalies</b> are seen in 68%-90% of individuals with 60% having tetramelic involvement. A wide variety of limb abnormalities are reported including syndactyly, oligodactyly, split-hand/foot malformation and digital duplication. A cohort of 152 EEC syndrome patients showed split-hand/foot malformation in 68% and syndactyly in 43% [<a class="bk_pop" href="#aec.REF.rinne.2006.1396">Rinne et al 2006a</a>].</p><p><b>Ectodermal defects</b></p><ul><li class="half_rhythm"><div><b>Skin</b> tends to be dry but erosions are not present.</div></li><li class="half_rhythm"><div><b>Hair changes</b> become more obvious with age and are seen in 60%-80% of individuals with EEC syndrome [<a class="bk_pop" href="#aec.REF.rinne.2006.1396">Rinne et al 2006a</a>]. Hair is typically silvery-blond, coarse, and dry; 20% have sparse hair. Light microscopy has been reported to be normal in EEC syndrome [<a class="bk_pop" href="#aec.REF.pashayan.1974.105">Pashayan et al 1974</a>]. Eyebrows and eyelashes are sparse.</div></li><li class="half_rhythm"><div><b>Nail</b>
<b>dysplasia</b> is commonly reported.</div></li><li class="half_rhythm"><div><b>Dental anomalies.</b> Malformed teeth (conical shape with small occlusal tables) and hypodontia (reduced number of teeth) also become evident during childhood and adolescence.</div></li><li class="half_rhythm"><div><b>Sweating.</b> Hypohidrosis is uncommon in EEC3 syndrome.</div></li></ul><p><b>Cleft lip with or without cleft palate</b> is present in 60%-75% and is bilateral in half of cases. Clefting can include submucous cleft palate only, cleft of the soft and/or the hard palate only, cleft lip only, or the combination of cleft lip and cleft palate [<a class="bk_pop" href="#aec.REF.buss.1995.716">Buss et al 1995</a>].</p><p><b>Absent lacrimal puncta</b> is reported in 90% of individuals and results in tearing, blepharitis, dacryocystitis, keratoconjunctivitis and photophobia and often lead to corneal ulceration and scaring [<a class="bk_pop" href="#aec.REF.buss.1995.716">Buss et al 1995</a>].</p><p><b>Genitourinary malformations</b> are reported in 45% and may include hypospadias and developmental abnormalities of the kidneys and urinary collecting system.</p></div><div id="aec.LimbMammary_Syndrome"><h4>Limb-Mammary Syndrome</h4><p>The manifestations limb-mammary syndrome are typically present at birth.</p><p><b>Limb anomalies,</b> including split-hand/foot malformation and syndactyly are reported in 75%-85% of individuals.</p><p><b>Breast and/or nipple hypoplasia</b> is seen commonly with almost all individuals having nipple aplasia or hypoplasia and 90% of females having mammary gland aplasia or hypoplasia. This feature is characteristic of ADULT and limb-mammary syndrome and NOT typically seen in other <i>TP63-</i>related disorders.</p><p><b>Lacrimal duct atresia</b> is seen in about half leading to chronic conjunctivitis and blepharitis, which are often not recognized until early childhood [<a class="bk_pop" href="#aec.REF.van_bokhoven.1999.538">van Bokhoven et al 1999</a>].</p><p><b>Ectodermal defects</b></p><ul><li class="half_rhythm"><div><b>Nail</b>
<b>dysplasia</b> is reported in 30% of individuals.</div></li><li class="half_rhythm"><div><b>Dental anomalies.</b> Hypodontia (reduced number of teeth) also become evident during childhood and adolescence and is seen in 10%-15%.</div></li></ul><p>Note: Skin and hair abnormalities are NOT typically seen, in contrast to other <i>TP63-</i>related disorders.</p><p><b>Cleft lip with or without cleft palate</b> is present in 25%-30% and can include submucous cleft palate only, cleft of the soft and/or the hard palate only, cleft lip only, or the combination of cleft lip and cleft palate.</p></div><div id="aec.SHFM4"><h4>SHFM4</h4><p>The manifestations of split-hand/foot malformation-4 (SHFM4) are typically present at birth.</p><p><b>Limb abnormalities</b> include median clefts of the hands and feet; aplasia/hypoplasia of phalanges, metacarpals, and metatarsals; and some syndactyly.</p><p><b>Ectodermal abnormalities and cleft lip/palate</b> are considered to be exclusion criteria for making the diagnosis SHFM4.</p></div><div id="aec.Orofacial_Cleft_8"><h4>Orofacial Cleft 8</h4><p><a class="bk_pop" href="#aec.REF.leoyklang.2006.e28">Leoyklang et al [2006]</a> have investigated the occurrence of <i>TP63</i> pathogenic variants in a cohort of 100 Thai patients <b>with nonsyndromic CL/P</b>. In total, 21 variant sites were identified. All were single nucleotide changes, with six in coding regions, including three novel nonsynonymous changes. No other features of <i>TP63-</i>related disorders were observed in these patients</p></div></div><div id="aec.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Note: Pathogenic variants have been described on two <i>TP63</i> <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>: the TAp63&#x003b1; isoform, encoded by NM_003722.4, and the &#x00394;Np63&#x003b1; isoform, encoded by NM_001114982.1, which is 39 amino acids shorter and has an alternate N-terminal TA <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. See <a href="#aec.Molecular_Genetics">Molecular Genetics</a> and <a class="figpopup" href="/books/NBK43797/figure/aec.F1/?report=objectonly" target="object" rid-figpopup="figaecF1" rid-ob="figobaecF1">Figure 1</a> for details.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figaecF1" co-legend-rid="figlgndaecF1"><a href="/books/NBK43797/figure/aec.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figaecF1" rid-ob="figobaecF1"><img class="small-thumb" src="/books/NBK43797/bin/aec-Image001.gif" src-large="/books/NBK43797/bin/aec-Image001.jpg" alt="Figure 1. . Typical and common TP63 pathogenic variants identified in various disorders as indicated by color key." /></a><div class="icnblk_cntnt" id="figlgndaecF1"><h4 id="aec.F1"><a href="/books/NBK43797/figure/aec.F1/?report=objectonly" target="object" rid-ob="figobaecF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Typical and common <i>TP63</i> pathogenic variants identified in various disorders as indicated by color key. Pathogenic variants indicated by * are specific for the &#x00394;Np63&#x003b1; isoform and their numbering is based on the respective reference sequences <a href="/books/NBK43797/figure/aec.F1/?report=objectonly" target="object" rid-ob="figobaecF1">(more...)</a></p></div></div><p><b>AEC syndrome.</b> All pathogenic variants associated with AEC syndrome occur in either the sterile alpha motif (SAM) <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (82%) or the &#x00394;Np63-specific N-terminal domain (18%). Pathogenic variants in the N-terminal domain that introduce premature termination codons lead to the use of an alternative start codon [<a class="bk_pop" href="#aec.REF.rinne.2008.1968">Rinne et al 2008</a>] and to the consequent production of &#x00394;Np63&#x003b1; <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> lacking the N-terminal domain, which are specifically associated with AEC syndrome. This isoform of p63 is the predominant isoform in mature epidermis, and it has been shown to repress ZNF750, leading to impaired epidermal differentiation [<a class="bk_pop" href="#aec.REF.zarnegar.2012.435">Zarnegar et al 2012</a>].</p><p><b>ADULT syndrome</b> is typically associated with pathogenic variants in the DNA binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> at p.Arg337 (TAp63&#x003b1;; formerly known as p.Arg298), such as c.1009C&#x0003e;G (p.Arg337Gly) and c.1010G&#x0003e;A (p.Arg337Gln). Other pathogenic variants have been reported in isolated patients with features reminiscent of ADULT syndrome, but also of other <i>TP63</i>-associated syndromes. Examples include c.16A&#x0003e;C (p.Asn6His in &#x00394;Np63&#x003b1;), which is in an alternative TA domain and c.518G&#x0003e;T (p.Gly173Asp in TAp63&#x003b1;) which is between the TA and DNA binding domains [<a class="bk_pop" href="#aec.REF.rinne.2006b.904">Rinne et al 2006b</a>, <a class="bk_pop" href="#aec.REF.rinne.2007.262">Rinne et al 2007</a>], and c.497C&#x0003e;T (p.Pro166Leu in TAp63&#x003b1;) [<a class="bk_pop" href="#aec.REF.van_zelststams.2009.1558">van Zelst-Stams &#x00026; van Steensel 2009</a>].</p><p><b>EEC3.</b> All EEC pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in the DNA binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and have been demonstrated to disrupt DNA binding [<a class="bk_pop" href="#aec.REF.rinne.2006b.904">Rinne et al 2006b</a>]. Splice changes and frameshifts associated with EEC have been reported [<a class="bk_pop" href="#aec.REF.celli.1999.143">Celli et al 1999</a>, <a class="bk_pop" href="#aec.REF.van_bokhoven.2001.481">van Bokhoven et al 2001</a>, <a class="bk_pop" href="#aec.REF.barrow.2002.559">Barrow et al 2002</a>, <a class="bk_pop" href="#aec.REF.monti.2013.894">Monti et al 2013</a>].</p><p><b>Limb-mammary syndrome.</b> Limb-mammary syndrome is caused by pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants that are located between the transactivation <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and the DNA binding domain (p.Gly115, p.Ser129, and p.Gly173 residues in TAp63&#x003b1;) or by truncating variants in the SAM domain of <i>TP63</i> [<a class="bk_pop" href="#aec.REF.van_bokhoven.2001.481">van Bokhoven et al 2001</a>, <a class="bk_pop" href="#aec.REF.rinne.2007.262">Rinne et al 2007</a>].</p><p><b>SHFM4.</b> Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in the TA and DNA binding domains have been associated with SHFM4 [<a class="bk_pop" href="#aec.REF.rinne.2007.262">Rinne et al 2007</a>].</p><p><b>Isolated cleft lip/cleft palate (orofacial cleft 8)</b> has been associated with <i>TP63</i> variants in the DNA binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [<a class="bk_pop" href="#aec.REF.leoyklang.2006.e28">Leoyklang et al 2006</a>]. Of these variants, p.Arg352Gly in TAp63&#x003b1; was concluded to be pathogenic on the basis of its amino acid change, evolutionary conservation, its occurrence in a functionally important domain, its predicted damaging function, its <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> occurrence, and its absence in 500 control individuals.</p><p>See <a class="figpopup" href="/books/NBK43797/figure/aec.F1/?report=objectonly" target="object" rid-figpopup="figaecF1" rid-ob="figobaecF1">Figure 1</a>.</p></div><div id="aec.Penetrance"><h3>Penetrance</h3><p>Reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> or possible <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> has been documented in a small number of individuals and families.</p><p>Reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> for split-hand/foot malformation type 4 (SHFM4) [<a class="bk_pop" href="#aec.REF.spranger.1988.202">Spranger &#x00026; Schapera 1988</a>] and ADULT syndrome [<a class="bk_pop" href="#aec.REF.amiel.2001.642">Amiel et al 2001</a>] has been reported.</p><p>A few individuals who do not appear to be clinically <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> have had more than one child with AEC syndrome. These occurrences may be the result of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, but are more likely caused by somatic and <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in one parent.</p><p>In one family, the <i>TP63</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> present in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fraternal twins was seen in the phenotypically normal mother. The data suggested <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> in the mother [van Bokhoven, unpublished data] with presumed <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</p></div><div id="aec.Nomenclature"><h3>Nomenclature</h3><p>Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome is also known as Hay-Wells syndrome after the physicians who first described the condition in 1976.</p><p>Rapp-Hodgkin syndrome (RHS), once considered a separate entity, is now considered to be part of the spectrum of the AEC syndrome because of the overlap of clinical manifestations and <i>TP63</i> pathogenic variants in the two conditions [<a class="bk_pop" href="#aec.REF.cambiaghi.1994.97">Cambiaghi et al 1994</a>, <a class="bk_pop" href="#aec.REF.mcgrath.2001.221">McGrath et al 2001</a>].</p><p>EEC3 is thought to be genetically unrelated to EEC1 (which has been mapped to <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 7q11q21). An entity called EEC2 was initially mapped to chromosome 19 [<a class="bk_pop" href="#aec.REF.o_quinn.1998.130">O&#x02019;Quinn et al 1998</a>]; however pathogenic variants in <i>TP63</i> were ultimately identified [<a class="bk_pop" href="#aec.REF.celli.1999.143">Celli et al 1999</a>].</p></div><div id="aec.Prevalence"><h3>Prevalence</h3><p><i>TP63-</i>related disorders are rare. The prevalence of disorders individually or collectively is unknown.</p></div></div><div id="aec.Genetically_Related_Allelic_Disorder"><h2 id="_aec_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>TP63</i>.</p></div><div id="aec.Differential_Diagnosis"><h2 id="_aec_Differential_Diagnosis_">Differential Diagnosis</h2><div id="aec.AEC_Syndrome_1"><h3>AEC Syndrome</h3><p><a href="/books/n/gene/ebs/"><b>Epidermolysis bullosa</b></a><b>.</b> Because of the presence of skin erosions at birth, many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are misdiagnosed with <a href="/books/n/gene/ebs/">epidermolysis bullosa</a>; however, the erosions of AEC syndrome are typically more superficial and not associated with formation of bullae. In addition to the nondermatologic phenotypic differences, dermatopathology should distinguish epidermolysis bullosa from AEC syndrome. The presence of erythroderma with a collodion membrane can also lead to an initial misdiagnosis of <a href="/books/n/gene/li-ar/">ichthyosis</a> in the newborn period [<a class="bk_pop" href="#aec.REF.siegfried.2005.1591">Siegfried et al 2005</a>].</p><p><b>Curly hair-ankyloblepharon-nail dysplasia syndrome (CHANDS)</b> (OMIM <a href="http://omim.org/entry/214350" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">214350</a>) has the overlapping features of ankyloblepharon and hair changes, but it does not typically include the significant facial/oral clefting or skin erosions that are virtually universal in AEC syndrome.</p></div><div id="aec.EEC3"><h3>EEC3</h3><p>EEC1 (OMIM <a href="http://omim.org/entry/129900" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">129900</a>) is suspected to be caused by pathogenic variants in a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 7q21q22 based on a series of individuals with various cytogenetically visible chromosomal abnormalities.</p><p>Other EEC syndrome-like phenotypes that do not appear to involve the EEC1 and EEC3 loci have been described.</p></div><div id="aec.SHFM4_1"><h3>SHFM4</h3><p><b>SHFM1</b> (OMIM <a href="http://omim.org/entry/183600" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">183600</a>) is caused by deletions of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 7q21 involving <i>DLX5</i> and <i>DLX6</i> as well as <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> pathogenic variants in <i>DLX5</i> and is associated with a high incidence of hearing loss. Findings in this disorder are largely restricted to the limbs. Dental and lacrimal duct abnormalities are seen in fewer than 10% of individuals [<a class="bk_pop" href="#aec.REF.elliott.2006.1419">Elliott &#x00026; Evans 2006</a>].</p><p><b>SHFM2</b> (OMIM <a href="http://omim.org/entry/313350" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">313350</a>) has been mapped to Xq26 and while both males and females are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, males tend to have a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Cleft lip/palate and ectodermal defects are not seen in this condition.</p><p><b>SHFM3</b> (OMIM <a href="http://omim.org/entry/246560" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">246560</a>) is caused by a contiguous <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 10q24 and does not have lacrimal, dental, or ectodermal abnormalities (beyond nail abnormalities associated with developmental defects of the digits) [<a class="bk_pop" href="#aec.REF.de_mollerat.2003.1959">de Mollerat et al 2003</a>, <a class="bk_pop" href="#aec.REF.elliott.2006.1419">Elliott &#x00026; Evans 2006</a>].</p><p><b>SHFM5</b> (OMIM <a href="http://omim.org/entry/606708" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606708</a>) is caused by deletions of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 2q31. Abnormally shaped teeth may be present, but neither oligodontia nor other ectodermal defects that may be seen in SHFM4 are reported. Dysmorphic facial features tend to be present [<a class="bk_pop" href="#aec.REF.elliott.2006.1419">Elliott &#x00026; Evans 2006</a>].</p><p><b>SHFM6</b> (OMIM <a href="http://omim.org/entry/225300" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">225300</a>) has been attributed to <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> pathogenic variants in <i>WNT10B</i>. Interestingly, all but one of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in the initial <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a> also had promoter <a class="def" href="/books/n/gene/glossary/def-item/polymorphism/">polymorphism</a> in <i>TP63</i> [<a class="bk_pop" href="#aec.REF.ugur.2008.2644">Ugur &#x00026; Tolun 2008</a>].</p></div><div id="aec.TP63Related_Disorders_Generally"><h3><i>TP63</i>-Related Disorders Generally</h3><p><a href="/books/n/gene/x-hed/"><b>Hypohidrotic ectodermal dysplasia</b></a>
<b>(HED)</b> is characterized by hypotrichosis (sparseness of scalp and body hair), hypohidrosis (reduced ability to sweat), and hypodontia (<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> absence of teeth). In HED the hypohidrosis is severe enough to impair body temperature regulation, a problem not seen in AEC syndrome. Orofacial clefting, universal in AEC syndrome, is not typically seen in HED.</p></div></div><div id="aec.Management"><h2 id="_aec_Management_">Management</h2><div id="aec.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with a <i>TP63</i> related disorder, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Clinical genetics to aid in diagnosis, coordination of health surveillance, and genetic testing and counseling</div></li><li class="half_rhythm"><div>Dermatology to evaluate and treat related skin issues, especially erosions</div></li><li class="half_rhythm"><div>Gastroenterology for growth and nutrition issues</div></li><li class="half_rhythm"><div>Dietary if there are concerns about failure to thrive</div></li><li class="half_rhythm"><div>Ophthalmology for evaluation and treatment of ocular issues including ankyloblepharon, lacrimal duct atresia/obstruction, dry eyes, and blepharitis</div></li><li class="half_rhythm"><div>Plastic surgery to evaluate and repair cleft lip and palate or breast/nipple assymetry</div></li><li class="half_rhythm"><div>Otolaryngology for evaluation and treatment of recurrent otitis media and speech issues</div></li><li class="half_rhythm"><div>Audiology to evaluate for hearing loss</div></li><li class="half_rhythm"><div>Dental to evaluate and address issues of hypodontia</div></li><li class="half_rhythm"><div>Prosthodontics to address potential need for dental implants</div></li><li class="half_rhythm"><div>Psychology/psychiatry to address developmental issues and provide support for the individual and family by assisting in dealing with the impact of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> on a normal life</div></li></ul></div><div id="aec.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>A multidisciplinary approach is recommended including regular evaluations with specialists in clinical genetics, dermatology, ophthalmology, otolaryngology, audiology, dentistry and prosthodontics, plastic surgery, gastroenterology, and psychiatry.</p><p><b>Ankyloblepharon filiforme adnatum.</b> These strands of tissue between the upper and lower eyelids are often small and autolyse shortly after birth; larger ones may require surgical separation by an ophthalmologist.</p><p><b>Ectodermal defects</b></p><ul><li class="half_rhythm"><div>Wigs can be used, if desired, for the sparse hair and alopecia.</div></li><li class="half_rhythm"><div>There are no known therapies for the nail or skin pigment changes.</div></li><li class="half_rhythm"><div>Dentures should be considered in early childhood and the possibility of dental implants should be considered in the teens or early adult years.</div></li><li class="half_rhythm"><div>Sweating is not severely impaired and does not require special care.</div></li></ul><p><b>Skin erosions.</b> The skin erosions are difficult to treat and prone to excessive ineffective granulation response; they are at increased risk for secondary infection and are not responsive to most standard wound care regimens or antibiotic therapy [<a class="bk_pop" href="#aec.REF.julapalli.2009.1900">Julapalli et al 2009</a>]. Skin erosions should be treated with gentle wound care and periodic, dilute bleach soaks (Dakins solution) to prevent secondary infection.</p><p>Occlusive dressings should <b>not</b> be used as they tend to stimulate granulation tissue.</p><p>Secondary infections should be treated with topical or oral antibiotics or antifungal agents when appropriate. Empiric treatment (i.e., use of antibiotic without culture-proven infection) is not recommended.</p><p><b>Cleft lip/palate.</b> Clefting should be addressed as soon as developmentally possible. Typical feeding issues associated with clefting are seen and include: poor suck, difficulty coordinating feeding and breathing, and excessive air intake. A nurse, nutritionist, pediatrician, speech therapist, or other specialist familiar with the management of feeding issues in children with cleft lip/palate should be consulted. Early referral to a craniofacial surgeon for planning for surgical cleft repair is indicated.</p><p><b>Other</b></p><ul><li class="half_rhythm"><div>Weight should be followed closely with assessment for signs of failure to thrive. If optimization of oral caloric intake fails to improve growth, gastrostomy tube placement may be considered.</div></li><li class="half_rhythm"><div>Myringotomy is indicated as needed for conductive hearing loss resulting from chronic otitis media.</div></li><li class="half_rhythm"><div>Significant breast asymmetry in women may be corrected through plastic surgery.</div></li><li class="half_rhythm"><div>Psychological impact of the phenotypic features of the disorder on patient and family should also be considered and referrals made to psychiatry or psychology as appropriate.</div></li></ul></div><div id="aec.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>Infants with severe skin erosions should be monitored and treated aggressively for dehydration, electrolyte imbalances, malnutrition, and secondary infection and sepsis.</p></div><div id="aec.Surveillance"><h3>Surveillance</h3><p>Regular evaluation with a multidisciplinary team is recommended for evaluation and prompt treatment of disease manifestations. In particular:</p><ul><li class="half_rhythm"><div>Dental findings over time may warrant use of dental prosthetics.</div></li><li class="half_rhythm"><div>Periodic hearing evaluations should be performed as conductive hearing loss is common.</div></li></ul></div><div id="aec.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Prolonged exposure to sunlight should be avoided to prevent sunburn of hypopigmented areas and to prevent increasing the contrast between the patchy areas of hyper- and hypopigmentation seen in AEC syndrome. Reduced sun exposure can minimize freckling of skin in individuals with ADULT syndrome.</p></div><div id="aec.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the genetic status of apparently asymptomatic at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the <i>TP63</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family in order to identify as early as possible those who would benefit from prompt initiation of treatment and preventive measures.</p><p>See <a href="#aec.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="aec.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>No specific trials for therapies are being conducted at this time. An investigational product developed to activate mutated p53 in cancer therapy has been tested for its ability to activate mutated p63 protein carrying EEC3-associated amino acid substitutions. This compound, denoted APR-246/PRIMA-1MET, showed a beneficial effect on skin differentiation [<a class="bk_pop" href="#aec.REF.shalomfeuerstein.2013.2152">Shalom-Feuerstein et al 2013</a>, <a class="bk_pop" href="#aec.REF.shen.2013.2157">Shen et al 2013</a>].</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div><div id="aec.Other"><h3>Other</h3><p>The National Foundation for Ectodermal Dysplasias (NFED) (<a href="http://www.nfed.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nfed.org</a>) is an excellent resource for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, their families, and clinicians who care for these individuals.</p></div></div><div id="aec.Genetic_Counseling"><h2 id="_aec_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="aec.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>The <i>TP63</i>-related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="aec.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div class="half_rhythm">Approximately 30% of individuals diagnosed with AEC have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. This appears to be true for the other <i>TP63</i>-related disorders as well [van Bokhoven H, Bree AF, Sutton VR; unpublished data].</div></li><li class="half_rhythm"><div class="half_rhythm">A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a <i>TP63</i>-related disorder may have the disorder as the result of a new <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of individuals with AEC caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>TP63</i> pathogenic variant is approximately 70%. This appears to be true for the other <i>TP63</i>-related disorders as well [van Bokhoven H, Bree AF, Sutton VR; unpublished data].</div><div class="half_rhythm">If the <i>TP63</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, two possible explanations are <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent or a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband.</div><div class="half_rhythm">In one family, the <i>TP63</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> present in fraternal twins was identified in the phenotypically normal mother. Further study of the mother suggested somatic and <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [van Bokhoven, unpublished data].</div></li><li class="half_rhythm"><div class="half_rhythm">The family history of some individuals diagnosed with a <i>TP63</i>-related disorder may appear to be negative because of failure to recognize the disorder in family members. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations (physical exam and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>) have been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband&#x02019;s parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected and/or the <i>TP63</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with a <i>TP63</i>-related disorder has a 50% chance of inheriting the <i>TP63</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x02019;s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be at risk.</p></div><div id="aec.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#aec.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a <i>TP63</i>-related disorder has the pathogenic variant or clinical evidence of the disorder<b>,</b> the <i>TP63</i> pathogenic variant is likely <i>de novo</i>. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="aec.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p>Once the <i>TP63</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> for a <i>TP63</i>-related disorder are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="aec.Resources"><h2 id="_aec_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Foundation for Ectodermal Dysplasias (NFED)</b></div><div>410 East Main Street</div><div>PO Box 114</div><div>Mascoutah IL 62258-0114</div><div><b>Phone:</b> 618-566-2020</div><div><b>Fax:</b> 618-566-4718</div><div><b>Email:</b> info@nfed.org</div><div><a href="http://www.nfed.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nfed.org</a></div></li><li class="half_rhythm"><div><b>Asociaci&#x000f3;n de Afectados por Displasia Ectod&#x000e9;rmica</b></div><div><i>Consumer health-oriented organization for Spain.</i></div><div>C Poet Andres Bolar&#x000ed;n</div><div>2-3&#x000ba; Dcha.</div><div>Murcia 30011</div><div>Spain</div><div><b>Phone:</b> 968 350 026</div><div><b>Email:</b> info@displasiaectodermica.org</div><div><a href="http://www.displasiaectodermica.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.displasiaectodermica.org</a></div></li><li class="half_rhythm"><div><b>Children's Craniofacial Association (CCA)</b></div><div>13140 Coit Road</div><div>Suite 517</div><div>Dallas TX 75240</div><div><b>Phone:</b> 800-535-3643 (toll-free)</div><div><b>Email:</b> contactCCA@ccakids.com</div><div><a href="https://ccakids.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ccakids.org</a></div></li><li class="half_rhythm"><div><b>Cleft Palate Foundation (CPF)</b></div><div>1504 East Franklin Street</div><div>Suite 102</div><div>Chapel Hill NC 27514-2820</div><div><b>Phone:</b> 800-242-5338 (toll-free); 919-933-9044</div><div><b>Fax:</b> 919-933-9604</div><div><b>Email:</b> info@cleftline.org</div><div><a href="http://www.cleftline.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cleftline.org</a></div></li><li class="half_rhythm"><div><b>Ectodermal Dysplasia Society</b></div><div>108 Charlton Lane</div><div>Cheltenham Gloucestershire GL53 9EA</div><div>United Kingdom</div><div><b>Phone:</b> 01242 261332</div><div><b>Email:</b> diana@ectodermaldysplasia.org</div><div><a href="http://www.ectodermaldysplasia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ectodermaldysplasia.org</a></div></li><li class="half_rhythm"><div><b>Face Equality International</b></div><div>United Kingdom</div><div><b>Email:</b> info@faceequalityinternational.org</div><div><a href="https://faceequalityinternational.org/thealliance/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.faceequalityinternational.org</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition/ankyloblepharon-ectodermal-defects-cleft-lip-palate-syndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome</a></div></li><li class="half_rhythm"><div><b>Selbsthilfegruppe Ektodermale Dysplasie e.V.</b></div><div><i>Consumer health-oriented organization for Germany, Austria, and Switzerland</i></div><div>Landhausweg 3</div><div>Aichtal D-72631</div><div>Germany</div><div><b>Phone:</b> 0 71 27 96 96 91</div><div><b>Fax:</b> 0 71 27 96 96 92</div><div><b>Email:</b> Burk-Aichtal@t-online.de</div><div><a href="http://www.ektodermale-dysplasie.de" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ektodermale-dysplasie.de</a></div></li><li class="half_rhythm"><div><b>Ectodermal Dysplasias International Registry</b></div><div>National Foundation for Ectodermal Dysplasias</div><div>410 East Main Street</div><div>Mascoutah IL 62258</div><div><b>Phone:</b> 618-566-2020</div><div><b>Fax:</b> 618-566-4718</div><div><b>Email:</b> info@nfed.org</div><div><a href="https://nfed.patientcrossroads.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ectodermal Dysplasias International Registry</a></div></li></ul></div><div id="aec.Molecular_Genetics"><h2 id="_aec_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="aec.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>TP63-Related Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK43797/table/aec.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__aec.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_aec.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_aec.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_aec.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_aec.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_aec.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_aec.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_aec.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/8626" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TP63</i></a></td><td headers="hd_b_aec.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=8626" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3q28</a></td><td headers="hd_b_aec.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9H3D4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Tumor protein 63</a></td><td headers="hd_b_aec.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/TP63" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TP63 @ LOVD</a></td><td headers="hd_b_aec.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TP63" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TP63</a></td><td headers="hd_b_aec.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TP63[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TP63</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="aec.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="aec.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for TP63-Related Disorders (<a href="/omim/103285,106260,129400,603273,603543,604292,605289" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK43797/table/aec.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__aec.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/103285" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">103285</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ADULT SYNDROME</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/106260" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">106260</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE; AEC</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/129400" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">129400</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">RAPP-HODGKIN SYNDROME; RHS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603273" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603273</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TUMOR PROTEIN p63; TP63</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603543" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603543</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LIMB-MAMMARY SYNDROME; LMS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604292" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604292</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605289" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605289</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPLIT-HAND/FOOT MALFORMATION 4; SHFM4</td></tr></tbody></table></div></div><p><b>Gene structure.</b> Many <i>TP63</i> transcripts encoding different proteins have been reported but the biologic validity and the full-length nature of these variants have not been determined [NCBI RefSeq]. See <a href="/gene/8626?ordinalpos=1&#x00026;itool=EntrezSystem2.PEntrez.Gene.Gene_ResultsPanel.Gene_RVDocSum" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NCBI Gene</a> for <i>TP63</i> transcript variants. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK43797/#aec.molgen.TA">Table A</a>, <b>Gene</b>.</p><p>The transcript variant <a href="/nuccore/169234655" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003722.4</a> has 16 exons and is the longest <i>TP63</i> transcript; it encodes the longest protein, isoform 1 (also known as TAp63&#x003b1;, KET, and p51B). The transcript variant (6), <a href="/nuccore/NM_001114982.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001114982.1</a>, differs in the 5&#x02032; UTR and <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a>, and in the 3&#x02032; UTR and coding region, compared to variant 1. The resulting protein (isoform 6, also known as &#x00394;Np63&#x003b3;) is shorter and has distinct N- and C-termini, compared to isoform 1.</p><p>Note: The nomenclature for <i>TP63</i> pathogenic variants is problematic. The reason for confusion is that the reference sequence for <i>TP63</i> has been changed over the years. The original reference sequence for TAp63&#x003b1; was defined by the <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> with accession number AF075430, which encodes a protein of 641 amino acids. This is the cDNA reported in <a class="bk_pop" href="#aec.REF.yang.1998.305">Yang et al [1998]</a>. The numbering of pathogenic variants is based on this clone (except for those that are specific for the &#x00394;N 5&#x02032; end, which are based on <a href="/nuccore/NM_001114982.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001114982.1</a>). <a class="bk_pop" href="#aec.REF.yang.1998.305">Yang et al [1998]</a> also reported a protein with an extended 5&#x02032; end, which they denoted TA*p63alpha. This protein encodes an additional 39 amino acids at the N-terminal end, resulting in a protein with a total of 680 amino acids. Later, this cDNA/protein (accession <a href="/nuccore/169234655" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003722.4</a>) became the reference sequence for TAp63&#x003b1;. Taking this sequence as a reference, all previously reported pathogenic variants should also be renamed by adding 39 amino acids. For example, p.Arg298Gly would be p.Arg337Gly (<a class="figpopup" href="/books/NBK43797/table/aec.T.selected_tp63_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figaecTselectedtp63pathogenicvariants" rid-ob="figobaecTselectedtp63pathogenicvariants">Table 3</a>).</p><p><b>Pathogenic variants.</b> Heterozygous pathogenic variants in <i>TP63</i> cause AEC syndrome, ADULT syndrome, EEC3, Limb-mammary syndrome, and SHFM4 (see <a href="#aec.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>).</p><div id="aec.T.selected_tp63_pathogenic_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>TP63</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK43797/table/aec.T.selected_tp63_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__aec.T.selected_tp63_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.16A&#x0003e;C</td><td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn6His</td><td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_001114982.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001114982<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/protein/NP_001108454.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001108454<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.497C&#x0003e;T</td><td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro166Leu</td><td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_3" rowspan="6" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_003722.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003722<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_003713.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_003713<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.518G&#x0003e;A</td><td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly173Asp<br />(Gly134Asp)&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1009C&#x0003e;G</td><td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg337Gly<br />(Arg298Gly)&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1010G&#x0003e;A</td><td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg337Gln<br />(Arg298Gln)&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1054A&#x0003e;G</td><td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg342Gly</td></tr><tr><td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1963delC</td><td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg655GlufsTer49</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="aec.TF.3.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="aec.TF.3.2"><p class="no_margin">In these instances, alias nomenclature is based on sequence AF075430.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> This gene encodes a member of the p53 family of transcription factors. The transcript variant NM_003722.4 is the longest <i>TP63</i> transcript and encodes the longest protein of 680 amino acid residues (isoform 1, also known as TAp63&#x003b1;, KET, and p51B). The transcript variant <a href="/nuccore/NM_001114982.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001114982.1</a> encodes isoform 6, also known as &#x00394;Np63&#x003b3; (<a href="/protein/NP_001108454.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001108454.1</a>), which is shorter and has distinct N- and C-termini, compared to isoform 1.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> TP63 is a master regulator of the embryonic development and differentiation of ectodermal cells [<a class="bk_pop" href="#aec.REF.shalomfeuerstein.2013.2152">Shalom-Feuerstein et al 2013</a>]. Additionally, it plays a critical role in the development of the apical ectodermal ridge of the limb bud in collaboration with the signaling molecule FGF8 [<a class="bk_pop" href="#aec.REF.restelli.2014.3830">Restelli et al 2014</a>].</p></div><div id="aec.References"><h2 id="_aec_References_">References</h2><div id="aec.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="aec.REF.amiel.2001.642">Amiel J, Bougeard G, Francannet C, Raclin V, Munnich A, Lyonnet S, Frebourg T. TP63 gene mutation in ADULT syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2001;<span class="ref-vol">9</span>:642–5.</span> [<a href="/pubmed/11528512" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11528512</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.aradhya.2012.594">Aradhya S, Lewis R, Bonaga T, Nwokekeh N, Stafford A, Boggs B, Hruska K, Smaoul N, Compton JG, Richard G, Suchy S. Exon-level array CGH in a large clinical cohort demonstrates increased sensitivity of diagnostic testing for Mendelian disorders. <span><span class="ref-journal">Genet Med. </span>2012;<span class="ref-vol">14</span>:594–603.</span> [<a href="/pubmed/22382802" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22382802</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.barrow.2002.559">Barrow LL, van Bokhoven H, Daack-Hirsch S, Andersen T, van Beersum SE, Gorlin R, Murray JC. Analysis of the p63 gene in classical EEC syndrome, related syndromes, and non-syndromic orofacial clefts. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:559–66.</span> [<a href="/pmc/articles/PMC1735218/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735218</span></a>] [<a href="/pubmed/12161593" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12161593</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.bertola.2004.79">Bertola DR, Kim CA, Albano LM, Scheffer H, Meijer R, van Bokhoven H. Molecular evidence that AEC syndrome and Rapp-Hodgkin syndrome are variable expression of a single genetic disorder. <span><span class="ref-journal">Clin Genet. </span>2004;<span class="ref-vol">66</span>:79–80.</span> [<a href="/pubmed/15200513" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15200513</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.buss.1995.716">Buss PW, Hughes HE, Clarke A. Twenty-four cases of the EEC syndrome: clinical presentation and management. <span><span class="ref-journal">J Med Genet. </span>1995;<span class="ref-vol">32</span>:716–23.</span> [<a href="/pmc/articles/PMC1051673/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1051673</span></a>] [<a href="/pubmed/8544192" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8544192</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.cambiaghi.1994.97">Cambiaghi S, Tadini G, Barbareschi M, Menni S, Caputo R. Rapp-Hodgkin syndrome and AEC syndrome: Are they the same entity? <span><span class="ref-journal">Br J Dermatol. </span>1994;<span class="ref-vol">130</span>:97–101.</span> [<a href="/pubmed/8305327" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8305327</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.celli.1999.143">Celli J, Duijf P, Hamel BC, Bamshad M, Kramer B, Smits AP, Newbury-Ecob R, Hennekam RC, Van Buggenhout G, van Haeringen A, Woods CG, van Essen AJ, de Waal R, Vriend G, Haber DA, Yang A, McKeon F, Brunner HG, van Bokhoven H. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. <span><span class="ref-journal">Cell. </span>1999;<span class="ref-vol">99</span>:143–53.</span> [<a href="/pubmed/10535733" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10535733</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.cole.2009.1910">Cole P, Hatef DA, Kaufman Y, Magruder A, Bree A, Friedman E, Sindwani R, Hollier LH Jr. Facial clefting and oroauditory pathway manifestations in ankyloblepharon-ectodermal defects-cleft lip/palate syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2009;<span class="ref-vol">149A</span>:1910–5.</span> [<a href="/pubmed/19697430" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19697430</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.de_mollerat.2003.1959">de Mollerat XJ, Gurrieri F, Morgan CT, Sangiorgi E, Everman DB, Gaspari P, Amiel J, Bamshad MJ, Lyle R, Blouin JL, Allanson JE, Le Marec B, Wilson M, Braverman NE, Radhakrishna U, Delozier-Blanchet C, Abbott A, Elghouzzi V, Antonarakis S, Stevenson RE, Munnich A, Neri G, Schwartz CE. A genomic rearrangement resulting in a tandem duplication is associated with split hand-split foot malformation 3 (SHFM3) at 10q24. <span><span class="ref-journal">Hum Mol Genet. </span>2003;<span class="ref-vol">12</span>:1959–71.</span> [<a href="/pubmed/12913067" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12913067</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.dishop.2009.1935">Dishop MK, Bree AF, Hicks MJ. Pathologic changes of skin and hair in ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2009;<span class="ref-vol">149A</span>:1935–41.</span> [<a href="/pubmed/19697429" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19697429</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.elliott.2006.1419">Elliott AM, Evans JA. Genotype-phenotype correlations in mapped split hand foot malformation (SHFM) patients. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:1419–27.</span> [<a href="/pubmed/16688749" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16688749</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.farrington.2009.1907">Farrington F, Lausten L. Oral findings in ankyloblepharon-ectodermal dysplasia-cleft lip/palate (AEC) syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2009;<span class="ref-vol">149A</span>:1907–9.</span> [<a href="/pubmed/19681142" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19681142</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.julapalli.2009.1900">Julapalli MR, Scher RK, Sybert VP, Siegfried EC, Bree AF. Dermatologic findings of ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:1900–6.</span> [<a href="/pubmed/19681128" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19681128</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.lane.2009.1926">Lane MM, Dalton WT 3rd, Sherman SA, Bree AF, Czyzewski DI. Psychosocial functioning and quality of life in children and families affected by AEC syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:1926–34.</span> [<a href="/pubmed/19504609" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19504609</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.leoyklang.2006.e28">Leoyklang P, Siriwan P, Shotelersuk V. A mutation of the p63 gene in non-syndromic cleft lip. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:e28</span> [<a href="/pmc/articles/PMC2564545/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2564545</span></a>] [<a href="/pubmed/16740912" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16740912</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.mcgrath.2001.221">McGrath JA, Duijf PH, Doetsch V, Irvine AD, de Waal R, Vanmolkot KR, Wessagowit V, Kelly A, Atherton DJ, Griffiths WA, Orlow SJ, van Haeringen A, Ausems MG, Yang A, McKeon F, Bamshad MA, Brunner HG, Hamel BC, van Bokhoven H. Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of TP63. <span><span class="ref-journal">Hum Mol Genet. </span>2001;<span class="ref-vol">10</span>:221–9.</span> [<a href="/pubmed/11159940" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11159940</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.monti.2013.894">Monti P, Russo D, Bocciardi R, Foggetti G, Menichini P, Divizia MT, Lerone M, Graziano C, Wischmeijer A, Viadiu H, Ravazzolo R, Inga A, Fronza G. EEC- and ADULT-associated TP63 mutations exhibit functional heterogeneity toward P63 responsive sequences. <span><span class="ref-journal">Hum Mutat. </span>2013;<span class="ref-vol">34</span>:894–904.</span> [<a href="/pubmed/23463580" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23463580</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.motil.2009.1922">Motil KJ, Fete TJ. Growth, nutritional, and gastrointestinal aspects of ankyloblepharon-ectodermal defect-cleft lip and/or palate (AEC) syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:1922–5.</span> [<a href="/pubmed/19676058" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19676058</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.o_quinn.1998.130">O&#x02019;Quinn JR, Hennekam RC, Jorde LB, Bamshad M. Syndromic ectrodactyly with severe limb, ectodermal, urogenital, and palatal defects maps to chromosome 19. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">62</span>:130–5.</span> [<a href="/pmc/articles/PMC1376811/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1376811</span></a>] [<a href="/pubmed/9443880" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9443880</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.pashayan.1974.105">Pashayan HM, Pruzansky S, Solomon L. The EEC syndrome. Report of six patients. <span><span class="ref-journal">Birth Defects Orig Artic Ser. </span>1974;<span class="ref-vol">10</span>:105–27.</span> [<a href="/pubmed/4425508" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4425508</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.restelli.2014.3830">Restelli M, Lopardo T, Lo Iacono N, Garaffo G, Conte D, Rustighi A, Napoli M, Del Sal G, Perez-Morga D, Costanzo A, Merlo GR, Guerrini L. DLX5, FGF8 and Pin1 isomerase control &#x00394;Np63&#x003b1; protein stability during limb development: a regulatory loop at the basis of the S?HFM and EEC congenital malformations. <span><span class="ref-journal">Hum Mol Genet. </span>2014;<span class="ref-vol">23</span>:3830–42.</span> [<a href="/pmc/articles/PMC4065156/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4065156</span></a>] [<a href="/pubmed/24569166" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24569166</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.rinne.2009.1948">Rinne T, Bolat E, Meijer R, Scheffer H, van Bokhoven H. Spectrum of p63 mutations in a selected patient cohort with ankyloblepharon-ectodermal defects-cleft lip/palate syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2009;<span class="ref-vol">149A</span>:1948–51.</span> [<a href="/pubmed/19676060" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19676060</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.rinne.2007.262">Rinne T, Brunner HG, van Bokhoven H. p63-associated disorders. <span><span class="ref-journal">Cell Cycle. </span>2007;<span class="ref-vol">6</span>:262–8.</span> [<a href="/pubmed/17224651" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17224651</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.rinne.2008.1968">Rinne T, Clements SE, Lamme E, Duijf PH, Bolat E, Meijer R, Scheffer H, Rosser E, Tan TY, McGrath JA, Schalkwijk J, Brunner HG, Zhou H, van Bokhoven H. A novel translation re-initiation mechanism for the p63 gene revealed by amino-terminal truncating mutations in Rapp-Hodgkin/Hay-Wells-like syndromes. <span><span class="ref-journal">Hum Mol Genet. </span>2008;<span class="ref-vol">17</span>:1968–77.</span> [<a href="/pubmed/18364388" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18364388</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.rinne.2006.1396">Rinne T, Hamel B, van Bokhoven H, Brunner HG. Pattern of p63 mutations and their phenotypes--update. <span><span class="ref-journal">Am J Med Genet A. </span>2006a;2006;<span class="ref-vol">140</span>:1396–406.</span> [<a href="/pubmed/16691622" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16691622</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.rinne.2006b.904">Rinne T, Spadoni E, Kjaer KW, Danesino C, Larizza D, Kock M, Huoponen K, Savontaus M-L, Aaltonen M, Duijf P, Brunner HG, Penttinen M, van Bokhoven H. Delineation of the ADULT syndrome phenotype due to arginine 298 mutgations of the p63 gene. <span><span class="ref-journal">Eur J Hum Genet. </span>2006b;<span class="ref-vol">14</span>:904–10.</span> [<a href="/pubmed/16724007" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16724007</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.shalomfeuerstein.2013.2152">Shalom-Feuerstein R, Serror L, Aberdam E, M&#x000fc;ller FJ, van Bokhoven H, Wiman KG, Zhou H, Aberdam D, Petit I. Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia-related patients is rescued by the small compound APR-246/PRIMA-1MET. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2013;<span class="ref-vol">110</span>:2152–6.</span> [<a href="/pmc/articles/PMC3568301/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3568301</span></a>] [<a href="/pubmed/23355677" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23355677</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.shen.2013.2157">Shen J, van den Bogaard EH, Kouwenhoven EN, Bykov VJ, Rinne T, Zhang Q, Tjabringa GS, Gilissen C, van Heeringen SJ, Schalkwijk J, van Bokhoven H, Wiman KG, Zhou H. APR-246/PRIMA-1(MET) rescues epidermal differentiation in skin keratinocytes derived from EEC syndrome patients with p63 mutations. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2013;<span class="ref-vol">110</span>:2157–62.</span> [<a href="/pmc/articles/PMC3568378/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3568378</span></a>] [<a href="/pubmed/23355676" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23355676</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.siegfried.2005.1591">Siegfried E, Bree A, Fete M, Sybert V. Skin erosions and wound healing in ankyloblepharon-ectodermal defect &#x02013; cleft lip and/or palate. <span><span class="ref-journal">Arch Dermatol. </span>2005;<span class="ref-vol">141</span>:1591–4.</span> [<a href="/pubmed/16365264" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16365264</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.spranger.1988.202">Spranger M, Schapera J. Anomalous inheritance in a kindred with split hand, split foot malformation. <span><span class="ref-journal">Eur J Pediatr. </span>1988;<span class="ref-vol">147</span>:202–5.</span> [<a href="/pubmed/3366140" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3366140</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.sutton.2009.1916">Sutton VR, Plunkett K, Dang DX, Lewis RA, Bree AF, Bacino CA. Craniofacial and anthropometric phenotype in ankyloblepharon-ectodermal defects-cleft lip/palate syndrome (Hay-Wells syndrome) in a cohort of 17 patients. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:1916–21.</span> [<a href="/pubmed/19676059" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19676059</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.ugur.2008.2644">Ugur SA, Tolun A. Homozygous WNT10b mutation and complex inheritance in Split-Hand/Foot Malformation. <span><span class="ref-journal">Hum Mol Genet. </span>2008;<span class="ref-vol">17</span>:2644–53.</span> [<a href="/pubmed/18515319" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18515319</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.van_bokhoven.2001.481">van Bokhoven H, Hamel BC, Bamshad M, Sangiorgi E, Gurrieri F, Duijf PH, Vanmolkot KR, van Beusekom E, van Beersum SE, Celli J, Merkx GF, Tenconi R, Fryns JP, Verloes A, Newbury-Ecob RA, Raas-Rotschild A, Majewski F, Beemer FA, Janecke A, Chitayat D, Crisponi G, Kayserili H, Yates JR, Neri G, Brunner HG. p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">69</span>:481–92.</span> [<a href="/pmc/articles/PMC1235479/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1235479</span></a>] [<a href="/pubmed/11462173" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11462173</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.van_bokhoven.1999.538">van Bokhoven H, Jung M, Smits AP, van Beersum S, R&#x000fc;schendorf F, van Steensel M, Veenstra M, Tuerlings JH, Mariman EC, Brunner HG, Wienker TF, Reis A, Ropers HH, Hamel BC. Limb mammary syndrome: a new genetic disorder with mammary hypoplasia, ectrodactyly, and other Hand/Foot anomalies maps to human chromosome 3q27. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">64</span>:538–46.</span> [<a href="/pmc/articles/PMC1377763/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377763</span></a>] [<a href="/pubmed/9973291" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9973291</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.van_zelststams.2009.1558">van Zelst-Stams WA, van Steensel MA. A novel TP63 mutation in family with ADULT syndrome presenting with eczema and hypothelia. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:1558–60.</span> [<a href="/pubmed/19530185" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19530185</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.yang.1998.305">Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, D&#x000f6;tsch V, Andrews NC, Caput D, McKeon F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. <span><span class="ref-journal">Mol Cell. </span>1998;<span class="ref-vol">2</span>:305–16.</span> [<a href="/pubmed/9774969" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9774969</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aec.REF.zarnegar.2012.435">Zarnegar BJ, Webster DE, Lopez-Pajares V, Vander Stoep Hunt B, Qu K, Yan KJ, Berk DR, Sen GL, Khavari PA. Genomic profiling of a human organotypic model of AEC syndrome reveals ZNF750 as an essential downstream target of mutant TP63. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">91</span>:435–43.</span> [<a href="/pmc/articles/PMC3511987/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3511987</span></a>] [<a href="/pubmed/22922031" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22922031</span></a>]</div></li></ul></div></div><div id="aec.Chapter_Notes"><h2 id="_aec_Chapter_Notes_">Chapter Notes</h2><div id="aec.Author_Notes"><h3>Author Notes</h3><p><a href="https://findaphysician.bcm.edu/search/#/listing/1154" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Dr Sutton&#x02019;s web page</a></p><p><a href="http://www.rimls.nl/people/b/bokhoven-van/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Dr van Bokhoven&#x02019;s web page</a></p></div><div id="aec.Acknowledgments"><h3>Acknowledgments</h3><p>The authors would like to thank the National Foundation for Ectodermal Dysplasias and Executive Director Mary Fete, who organized the International Research Symposium on AEC syndrome, and all the individuals and families who participated in the research that contributed to this review. Additionally, we would like to express our gratitude to Dr John Carey and the American Journal of Medical Genetics for publishing these research results in a unified special issue of the journal.</p></div><div id="aec.Author_History"><h3>Author History</h3><p>Alanna F Bree, MD; Dermatology Specialists of Houston (2010-2015)<br />V Reid Sutton, MD (2010-present)<br />Hans van Bokhoven, PhD (2010-present)</p></div><div id="aec.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>5 December 2019 (vrs) Revision: correction to SHFM4</div></li><li class="half_rhythm"><div>6 August 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 June 2010 (me) Review posted live</div></li><li class="half_rhythm"><div>2 February 2010 (vrs) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK43797</span><span class="label">PMID: <a href="/pubmed/20556892" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20556892</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/tk2-mtddepl/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/trio-id/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK43797&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK43797/?report=reader">PubReader</a></li><li><a href="/books/NBK43797/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK43797" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK43797" style="display:none" title="Cite this Page"><div class="bk_tt">Sutton VR, van Bokhoven H. TP63-Related Disorders. 2010 Jun 8 [Updated 2019 Dec 5]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK43797/pdf/Bookshelf_NBK43797.pdf">PDF version of this page</a> (729K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#aec.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#aec.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#aec.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#aec.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#aec.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#aec.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#aec.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#aec.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#aec.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#aec.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#aec.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#aec.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8626[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TP63</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK43797+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2170226" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2170226" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2170226" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2170226" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31420900" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A novel mutation (c.1010G&amp;gt;T; p.R337L) in TP63 as a cause of split-hand/foot malformation with hypodontia.</a><span class="source">[J Gene Med. 2019]</span><div class="brieflinkpop offscreen_noflow">A novel mutation (c.1010G&amp;gt;T; p.R337L) in TP63 as a cause of split-hand/foot malformation with hypodontia.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Jin JY, Zeng L, Li K, He JQ, Pang X, Huang H, Xiang R, Tang JY. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Gene Med. 2019 Oct; 21(10):e3122. Epub 2019 Aug 30.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301581" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">IRF6</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">IRF6</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Schutte BC, Saal HM, Goudy S, Leslie E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30088137" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Sweating ability of patients with p63-associated syndromes.</a><span class="source">[Eur J Pediatr. 2018]</span><div class="brieflinkpop offscreen_noflow">Sweating ability of patients with p63-associated syndromes.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ferstl P, Wohlfart S, Schneider H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Pediatr. 2018 Nov; 177(11):1727-1731. Epub 2018 Aug 7.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29440852" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Rare Variant of Ankyloblepharon-ectodermal Defect-cleft Lip/Cleft Palate Syndrome: Curly Hair-ankyloblepharon-nail Disease Syndrome.</a><span class="source">[Int J Trichology. 2018]</span><div class="brieflinkpop offscreen_noflow">Rare Variant of Ankyloblepharon-ectodermal Defect-cleft Lip/Cleft Palate Syndrome: Curly Hair-ankyloblepharon-nail Disease Syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chopra A, Mitra D, Kandpal R, Agarwal R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Int J Trichology. 2018 Jan-Feb; 10(1):17-20. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27351625" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Recurrence of split hand/foot malformation, cleft lip/palate, and severe urogenital abnormalities due to germline mosaicism for TP63 mutation.</a><span class="source">[Am J Med Genet A. 2016]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Recurrence of split hand/foot malformation, cleft lip/palate, and severe urogenital abnormalities due to germline mosaicism for TP63 mutation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Enriquez A, Krivanek M, Flöttmann R, Peters H, Wilson M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2016 Sep; 170(9):2372-6. Epub 2016 Jun 28.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20556892" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20556892" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041499dd21425a25dccb9c">TP63-Related Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">TP63-Related Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:02:01-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8AEEDBE040FA5100000000021F00BF&amp;ncbi_session=CE8AEEDBE0414981_0543SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK43797%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK43797&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK43797/&amp;ncbi_pagename=TP63-Related Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8AEEDBE0414981_0543SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>